EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast Cancer

Elisé G Kaboré, Conor Macdonald, Ahmed Kaboré, Romain Didier, Patrick Arveux, Nicolas Meda, Marie-Christine Boutron-Ruault, Charles Guenancia

JAMA Network Open · 23.02.2023 · 6 (2) · e230569

DOI: 10.1001/jamanetworkopen.2023.0569 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA Network Open, online erschienen am 23.02.2023. Verfasst von Elisé G Kaboré und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health across Generations Team, Inserm U1018, Centre for Research in Epidemiology and Population Health, Villejuif, France. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Cardiotoxicity is a serious adverse effect that can occur in women undergoing treatment for breast cancer. Identifying patients who will develop cardiotoxicity remains challenging.

Objective

To identify, describe, and evaluate all prognostic models developed to predict cardiotoxicity following treatment in women with breast cancer. Evidence Review This systematic review searched the Medline, Embase, and Cochrane databases up to September 22, 2021, to include studies developing or validating a prediction model for cardiotoxicity in women with breast cancer. The Prediction Model Risk of Bias Assessment Tool (PROBAST) was used to assess both the risk of bias and the applicability of the prediction modeling studies. Transparency reporting was assessed with the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) tool.

Findings

After screening 590 publications, we identified 7 prognostic model studies for this review. Six were model development studies and 1 was an external validation study. Outcomes included occurrence of cardiac dysfunction (echocardiographic parameters), heart failure, and composite clinical outcomes. Model discrimination, measured by the area under receiver operating curves or C statistic, ranged from 0.70 (95% IC, 0.62-0.77) to 0.87 (95% IC, 0.77-0.96). The most common predictors identified in final prediction models included age, baseline left ventricular ejection fraction, hypertension, and diabetes. Four of the developed models were deemed to be at high risk of bias due to analysis concerns, particularly for sample size, handling of missing data, and not presenting appropriate performance statistics. None of the included studies examined the clinical utility of the developed model. All studies met more than 80% of the items in TRIPOD checklist. Conclusions and Relevance In this systematic review of the 6 predictive models identified, only 1 had undergone external validation. Most of the studies were assessed as being at high overall risk of bias. Application of the reporting guidelines may help future research and improve the reproducibility and applicability of prediction models for cardiotoxicity following breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleStroke VolumeCardiotoxicityReproducibility of ResultsVentricular Function, Left

Autor:innen und Institutionen

  • Health across Generations Team, Inserm U1018, Centre for Research in Epidemiology and Population Health, Villejuif, France.
  • Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
  • Department of Cardiology, CHU Dijon-Bourgogne, Dijon, France.
  • Center for Primary Care and Public Health, Unisanté, University of Lausanne, Lausanne, Switzerland.

Zitieren

APA

Kaboré, E. G., Macdonald, C., Kaboré, A., Didier, R., Arveux, P., Meda, N., Boutron-Ruault, M. C., & Guenancia, C. (2023). Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast Cancer. JAMA Network Open, 6(2), e230569. https://doi.org/10.1001/jamanetworkopen.2023.0569

Vancouver

Kaboré EG, Macdonald C, Kaboré A, Didier R, Arveux P, Meda N, et al. Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast Cancer. JAMA Network Open. 2023;6(2):e230569. doi:10.1001/jamanetworkopen.2023.0569

BibTeX
@article{Kabor2023,
  author = {Kaboré, Elisé G and Macdonald, Conor and Kaboré, Ahmed and Didier, Romain and Arveux, Patrick and Meda, Nicolas and Boutron-Ruault, Marie-Christine and Guenancia, Charles},
  title = {Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast Cancer},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {2},
  pages = {e230569},
  doi = {10.1001/jamanetworkopen.2023.0569}
}
Kostenlos starten →